BioMedInvest II L.P. is a healthcare-dedicated venture capital fund that was closed in 2009 and has a size of CHF 106 million. It is based in Guernsey, Channel Islands, and provides private equity financing to early-stage private companies and spin-offs in the biotechnology, emerging pharmaceutical, medical technology and other healthcare-related industries such as diagnostics or platform technologies with a geographic focus on investments in Switzerland and neighbouring countries. 

BioMedInvest II L.P.'s investment strategy allows for investments in start-up companies looking for first round funding through to later-stage or spin-off companies focused on product development in the biotechnology, emerging pharmaceuticals, healthcare and medical technology sectors. 

The amount we aim to invest over the life time of our portfolio companies is about CHF 1 - 10 million. BioMedInvest typically plays the lead or co-lead investor role structuring the transaction and syndicating with other venture capital firms. BioMedInvest II invested in 16 companies, three of which have completed an exit (one trade sale, two going public).